Pfizer’s says its COVID-19 vaccine was 73% effective in protecting children younger than 5 as omicron spread in the spring.
A vial of the Pfizer COVID-19 vaccine for children 6 months through 4 years old is seen June 21, 2022, at Montefiore Medical Group in the Bronx borough of New York. New data from Pfizer and BioNTech show their tot-sized COVID-19 vaccine was 73% effective in protecting children younger than 5 as omicron spread in the spring. Vaccinations for babies, toddlers and preschoolers opened in the U.S. in June after months of delay.
Vaccinations for babies, toddlers and preschoolers opened in the U.S. in June after months of delay. Only about 6% of youngsters ages 6 months through 4 years had gotten at least one dose of a COVID-19 vaccine by mid-August, according to the American Academy of Pediatrics. The new update analyzed COVID-19 diagnoses between March and June in Pfizer's ongoing study of the three-dose vaccine. There were 21 COVID-19 cases among the 351 tots who got dummy shots -- compared to just 13 among the 794 youngsters given three vaccine doses.The child cases primarily were caused by the BA.2 omicron version that was circulating at the time. Today, another omicron relative, BA.5, is causing most COVID-19 cases in the U.S. and much of the world.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Pfizer COVID shots appear 73% effective in children under 5Pfizer’s COVID-19 vaccine was 73% effective in protecting children younger than 5 as omicron spread in the spring, the company announced Tuesday.
Consulte Mais informação »
Pfizer COVID shots appear 73% effective in children under 5Pfizer's COVID-19 vaccine was 73% effective in protecting children younger than 5 as omicron spread in the spring, the company announced Tuesday. Vaccinations for babies, toddlers and preschoolers opened in the U.S.
Consulte Mais informação »
Pfizer COVID Shots Appear 73% Effective in Children Under 5Vaccinations for babies, toddlers and preschoolers opened in the U.S. in June after months of delay. Only about 6% of youngsters ages 6 months through 4 years had gotten at least one dose of a COVID-19 vaccine by mid-August, according to the American Academy of Pediatrics.
Consulte Mais informação »
Myocarditis Risk Higher After COVID-19 Infection than After COVID-19 VaccinationThe risk of myocarditis is substantially higher in the 4 weeks after COVID-19 infection than after a first dose of a COVID-19 vaccine, say researchers of new study. CardioTwitter
Consulte Mais informação »
Post-COVID Symptoms in Kids: Not Always Long COVIDDo kids get long COVID? Look for these unique signs and symptoms. MedTwitter
Consulte Mais informação »
Long Covid: Mum puts hopes in experimental treatmentKate Stott will travel from Aberdeen to Germany to get experimental treatment for blood microclots.
Consulte Mais informação »